Karyopharm Therapeutics' Series B Round

Karyopharm Therapeutics raised a round of funding on May 20, 2013.

Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing small molecule modulators of nuclear transport. Karyopharm's selective inhibitors of nuclear export (SINE) function by tra…

Articles about Karyopharm Therapeutics' Series B Round: